Acute Lymphoblastic Leukemia Clinical Trials in Suzhou, Jiangsu
17 recruitingSuzhou, Jiangsu, China
Showing 1–17 of 17 trials
Recruiting
Phase 2
Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients
T-cell Acute Lymphoblastic LeukemiaRecruiting
The First Affiliated Hospital of Soochow University28 enrolled1 locationNCT05376111
Recruiting
Phase 2
Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaTransplantation, Stem Cell+1 more
The First Affiliated Hospital of Soochow University48 enrolled1 locationNCT06816134
Recruiting
Phase 1Phase 2
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
B Cell Precursor Acute Lymphoblastic Leukemia
Amgen281 enrolled86 locationsNCT04521231
Recruiting
Not Applicable
CAV Regimen for R/R Ph- B-ALL
Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University36 enrolled1 locationNCT05657652
Recruiting
Phase 1
Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies
Acute Lymphoblastic LeukemiaNon-Hodgkin Lymphoma
PersonGen BioTherapeutics (Suzhou) Co., Ltd.10 enrolled1 locationNCT07284927
Recruiting
Phase 1
Blinatumomab and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL
B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University4 enrolled1 locationNCT06507514
Recruiting
Phase 3
Newly-diagnosed Pediatric Ph-positive B-ALL Protocol
Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)Childhood Leukemia, Acute Lymphoblastic
Institute of Hematology & Blood Diseases Hospital, China150 enrolled24 locationsNCT07152041
Recruiting
Phase 2Phase 3
Newly-diagnosed Pediatric T-cell ALL Protocol
Acute Lymphoblastic LeukemiaChildhood Leukemia, Acute LymphoblasticT Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Institute of Hematology & Blood Diseases Hospital, China610 enrolled27 locationsNCT06855810
Recruiting
Phase 2Phase 3
Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
Childhood Leukemia, Acute LymphoblasticB-cell Acute Lymphoblastic Leukemia (B-ALL)Acute Lymphoblastic Leukemia ALL
Institute of Hematology & Blood Diseases Hospital, China3,000 enrolled27 locationsNCT06882057
Recruiting
Phase 2
Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy
Acute Lymphoblastic LeukemiaImmunotherapyBlinatumomab+1 more
The First Affiliated Hospital of Soochow University26 enrolled1 locationNCT06985485
Recruiting
Phase 2
Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations
T Acute Lymphoblastic LeukemiaEarly T Acute Lymphoblastic LeukemiaMixed Phenotype Acute Leukemia, T/Myeloid, Nos
yuejun Liu32 enrolled1 locationNCT07012447
Recruiting
Phase 2
CD22/CD19 CAR-T and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL
B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University37 enrolled1 locationNCT05470777
Recruiting
Phase 1Phase 2
CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia, Adult B-Cell
The First Affiliated Hospital of Soochow University34 enrolled1 locationNCT03984968
Recruiting
Phase 2Phase 3
Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
Childhood Leukemia, Acute LymphoblasticB-cell Acute Lymphoblastic Leukemia (B-ALL)Acute Lymphoblastic Leukemia ALL
Institute of Hematology & Blood Diseases Hospital, China1,800 enrolled26 locationsNCT06764238
Recruiting
Phase 2
Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALL
B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University30 enrolled1 locationNCT06393985
Recruiting
Phase 2
Chemotherapy-free Regimen of Venetoclax, Azacitidine Plus Orebatinib (VAO Regimen) for Newly Diagnosed ph+ALL
Ph-Positive Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University30 enrolled1 locationNCT06578546
Recruiting
Phase 2
A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents
Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic LeukemiaRelapsed Pediatric ALL
Chongqing Precision Biotech Co., Ltd100 enrolled10 locationsNCT05334823